keyword
MENU ▼
Read by QxMD icon Read
search

Corevalve

keyword
https://www.readbyqxmd.com/read/29628466/increase-carotid-flow-by-double-sheath-connection-technique-to-reduce-cerebral-ischemia-for-transcatheter-aortic-valve-implantation-through-transcarotid-approach
#1
Richard Tsai, I-Ming Chen, Po-Lin Chen, Hsin-Bang Leu, Ying-Hwa Chen, Hsiao-Huang Chang
PURPOSE: Transcarotid transcatheter aortic valve implantation (TAVI) is one alternative approach if unfavorable femoral access. However, this approach may cause cerebral vascular accidents (CVAs) by temporarily occluding common carotid artery (CCA). The purpose of this study is to develop a new method reducing cerebral ischemia during transcarotid TAVI. METHODS: We inserted an 8- and 18-Fr. sheath in CCA with tip toward brain and aortic arch, respectively, and connected their side arms to create a bypass flow...
April 6, 2018: Annals of Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/29622986/clinical-utility-of-a-predictive-model-for-paravalvular-aortic-regurgitation-after-transcatheter-aortic-valve-implantation-with-a-self-expandable-prosthesis
#2
Ahmad E Mostafa, Gert Richardt, Mohamed Abdel-Wahab
Background: A predictive model for Paravalvular aortic regurgitation (PAR) integrating the left ventricular outflow tract-to-ascending aorta angle (LVOT-AO) and depth to the non-coronary cusp (NCC) after TAVI with CoreValve prosthesis (MCP) was retrospectively identified (2 × ∠LVOT-AO + [depth to NCC-10]2; cutoff = 50). However, the validity and clinical utility of this model remain unknown. Methods: A total of 100 patients (79.6 ± 7 years, mean EuroScore 24...
December 2017: The Egyptian heart journal: (EHJ): official bulletin of the Egyptian Society of Cardiology
https://www.readbyqxmd.com/read/29617804/feasibility-of-transcatheter-aortic-valve-implantation-in-patients-with-coronary-heights-%C3%A2-7-mm-insights-from-the-transcatheter-aortic-valve-implantation-karlsruhe-tavik-registry
#3
Lars O Conzelmann, Alexander Würth, Gerhard Schymik, Holger Schröfel, Tonic Anusic, Stefanie Temme, Panagiotis Tzamalis, Jan Gerhardus, Chirojit Mukherjee, Bernd-Dieter Gonska, Claus Schmitt, Uwe Mehlhorn
OBJECTIVES: Transcatheter aortic valve implantation (TAVI) in patients with low coronary heights is generally denied but is not impossible. Information about these high-risk procedures is sparse. METHODS: Since May 2008, data of more than 3000 patients who had TAVI were prospectively collected in the institutional TAVI Karlsruhe registry. Characteristics, peri- and postoperative outcome of patients with low coronary heights of ≤7 mm were analysed according to the Valve Academic Research Consortium-2...
April 2, 2018: European Journal of Cardio-thoracic Surgery
https://www.readbyqxmd.com/read/29608814/impact-of-high-implantation-on-functionality-of-self-expandable-bioprosthesis-during-the-short-and-long-term-outcome-of-patients-who-undergo-tavi-is-high-implantation-beneficial
#4
Manolis Vavuranakis, Maria Kariori, Lilly Scott, Konstantinos Kalogeras, Gerasimos Siasos, Dimitrios Vrachatis, Maria Lavda, Charalampos Kalantzis, Michael Vavuranakis, Evangelia Bei, Carmen-Maria Moldovan, Evangelos Oikonomou, Christodoulos Stefanadis, Dimitrios Tousoulis
AIM: High position of the self-expandable bioprosthesis CoreValve/Evolut R has been proved to affect immediate hemodynamics of the valve. Whether this may have any impact on long-term procedural outcome has not been defined yet. The purpose of this study is to assess whether the final position of aortic bioprosthesis affects its long-term functionality. METHOD: Consecutive patients (pts) who underwent successful TAVI procedure were evaluated and separated into two groups according to the implantation depth (ID); Group I: pts with 4mm<ID≤13 mm, Group II: pts with ID≤4mm...
April 2, 2018: Cardiovascular Therapeutics
https://www.readbyqxmd.com/read/29599379/comparison-of-general-anaesthesia-and-non-general-anaesthesia-approach-in-transfemoral-transcatheter-aortic-valve-implantation
#5
Mehdi Eskandari, Omar Aldalati, Rafal Dworakowski, Jonathan A Byrne, Emma Alcock, Olaf Wendler, Philip A MacCarthy, Peter F Ludman, David J R Hildick-Smith, Mark J Monaghan
OBJECTIVE: Performing transfemoral transcatheter aortic valve implantation (TAVI) without general anaesthesia (GA) has been increasingly adopted. We sought to study the impact of GA and non-GA approaches on procedural outcome and 30-day and 1-year mortality in transfemoral TAVI. METHODS: The UK TAVI registry holds information for every TAVI procedure in the UK. We analysed the data for patients implanted during 2013-2014 using either an Edwards Sapien or a Medtronic CoreValve prosthesis...
March 29, 2018: Heart: Official Journal of the British Cardiac Society
https://www.readbyqxmd.com/read/29582947/-long-term-follow-up-of-transcatheter-self-expandable-aortic-valve-implantation
#6
Shmuel Chen, Vicky Zenios, Dan Gilon, David Planer, Ronen Beeri, Chaim Lotan, Haim D Danenberg
INTRODUCTION: Aortic stenosis is the most common significant valvular disease in the western world. These patients are treated operatively unless they are at high operative risk or inoperable. During the last decade an alternative approach has evolved - transcatheter aortic valve implantation (TAVI). This method was shown to be at least as effective and safe as the operative one. However, very little data exists on long term follow-up (5 years and above), especially regarding valve durability and patient survival...
March 2018: Harefuah
https://www.readbyqxmd.com/read/29581084/beyond-the-5-year-horizon-long-term-outcome-of-high-risk-and-inoperable-patients-undergoing-tavr-with-first-generation-devices
#7
Marcus-André Deutsch, Magdalena Erlebach, Melchior Burri, Alexander Hapfelmeier, Olivia Ganga Witt, Johannes Amadeus Ziegelmueller, Michael Wottke, Hendrik Ruge, Markus Krane, Nicolo Piazza, Sabine Bleiziffer, Rüdiger Lange
AIMS: We sought to determine the long-term outcome of high-risk patients who underwent transcatheter aortic valve replacement (TAVR) with first-generation devices with a focus on an identification of predictors for mortality and valve durability. METHODS AND RESULTS: Consecutive patients in our prospective single-center registry undergoing TAVR with first-generation devices (n=214 CoreValve; n=86 Sapien) between 06/2007 and 07/2009 were retrospectively analysed (n=300, mean age 81...
March 27, 2018: EuroIntervention
https://www.readbyqxmd.com/read/29570211/valve-in-valve-implantation-of-the-corevalve-evolut-r-in-degenerated-surgical-aortic-valves
#8
Marius Schwerg, Karl Stangl, Michael Laule, Verena Stangl, Henryk Dreger
BACKGROUND: The new CoreValve Evolut R has an improved design to minimize paravalvular leakage (PVL) and allows repositioning of the valve. For patients with degenerated bioprosthetic aortic valves, transcatheter aortic valve implantation (TAVI) represents a less invasive option. Herein reported are valve-in-valve (ViV) implantations of this new valve. METHODS: A total of 26 patients (mean age 79.4 ± 6.1 years, 17 males and 9 females) were treated for severe prosthesis stenosis (n = 9), severe regurgitation (n = 8) or severe combination of stenosis and regurgitation (n = 9)...
March 23, 2018: Cardiology Journal
https://www.readbyqxmd.com/read/29537371/effect-of-size-and-position-of-self-expanding-transcatheter-valve-on-hemodynamics-following-valve-in-valve-procedure-in-small-surgical-bioprostheses-an-in-vitro-study
#9
Anne-Sophie Zenses, Morgane A Evin, Viktória Stanová, Marie-Annick Clavel, Paul Barragan, Josep Rodés-Cabau, Jean-François Obadia, Philippe Pibarot, Régis Rieu
AIMS: Valve-in-Valve (ViV) procedure has become a valuable alternative for the treatment of failed surgical bioprostheses (BP) in high risk patients. However, in small BPs, the clinical outcomes have been suboptimal due to high post-procedural gradients. We aimed at examining the effect of size and position of the self-expanding transcatheter heart valve (THV) CoreValve on the hemodynamics of ViV within small BPs. METHODS AND RESULTS: Sizes 23 and 26 mm of the CoreValve were implanted in sizes 19 and 21 mm of 3 BP models: Trifecta, Mitroflow and Epic Supra...
March 13, 2018: EuroIntervention
https://www.readbyqxmd.com/read/29530883/hemodynamic-and-echocardiographic-comparison-of-the-lotus-and-corevalve-transcatheter-aortic-valves-in-patients-with-high-and-extreme-surgical-risk-an-analysis-from-the-reprise-iii-randomized-controlled-trial-repositionable-percutaneous-replacement-of-stenotic
#10
Federico M Asch, Mani A Vannan, Siddharth Singh, Bijoy Khandheria, Stephen H Little, Dominic J Allocco, Ian T Meredith, Ted E Feldman, Michael J Reardon, Neil J Weissman
BACKGROUND : Comparative echocardiographic data on transcatheter aortic valve replacement systems from randomized trials are limited. The REPRISE III trial (Repositionable Percutaneous Replacement of Stenotic Aortic Valve through Implantation of Lotus Valve System - Randomized Clinical Evaluation) is a multicenter, randomized comparison of a mechanically expanded (Lotus) versus self-expanding (CoreValve) transcatheter aortic valve replacement device. This analysis rigorously assesses Doppler-derived valve hemodynamics and the impact on outcomes at 1 year in patients with extreme/high surgical risk treated with Lotus and CoreValve from REPRISE III...
March 12, 2018: Circulation
https://www.readbyqxmd.com/read/29512361/transcatheter-aortic-valve-implantation-in-bicuspid-anatomy-procedural-results-with-two-different-types-of-valves
#11
Patrizia Presbitero, Loredana Iannetta, Paolo Pagnotta, Bernhard Reimers, Marco L Rossi, Dennis Zavalloni Parenti, Giovanni Bianchi, Francesco Bedogni
BACKGROUND: It is well known that bicuspid valve stenosis can be treated with transcatheter aortic valve implantation (TAVI) even if specific issues can cause problems: dilatation of ascending aorta, possible aorthopathy, eccentricity of the valve and calcium distribution in leaflets and in commissures. We classified Bicuspid aortic valve (BAV) in type 0 (2 cusps and no raphe), and type 1 (2 cusps and one or more raphes). The aim of the present study was to report the results of two types of valve (CoreValve from 2009 to 2016 and Lotus valve from 2014 to 2017) in a consecutive series of BAV patients treated in 2 Italian centers...
April 2018: Minerva Cardioangiologica
https://www.readbyqxmd.com/read/29490430/valve-in-valve-transcatheter-aortic-valve-implantation-with-corevalve-evolut-r-%C3%A2-for-degenerated-small-versus-bigger-bioprostheses
#12
Smita Scholtz, Cornelia Piper, Dieter Horstkotte, Jan Gummert, Stephan M Ensminger, Jochen Börgermann, Werner Scholtz
OBJECTIVES: We present our single center experience with Medtronic CoreValve and Evolut R regarding procedural outcome and 3 years follow-up in patients with degenerated bioprostheses. METHODS: From 1645 patients who underwent transfemoral TAVI at our institution between February 2009 and December 2016, 37 patients with degenerated bioprosthesis were treated with Medtronic CoreValve/Evolut R. All data concerning baseline characteristic, procedural outcomes and follow-up were entered into a dedicated database...
February 28, 2018: Journal of Interventional Cardiology
https://www.readbyqxmd.com/read/29462049/suprasternal-transcatheter-aortic-valve-replacement-in-patients-with-marginal-femoral-access
#13
Andy C Kiser, Thomas G Caranasos, Mark D Peterson, David M Holzhey, Philipp Kiefer, L Wiley Nifong, Michael A Borger
OBJECTIVE: Recently, the PARTNER 2A trial reported results of transcatheter aortic valve replacement versus surgical aortic valve replacement in 2032 intermediate-risk patients at 2 years. Two hundred thirty-six patients (24%) required an access route other than transfemoral. Compared with transfemoral and surgical aortic valve replacement, nontransfemoral transcatheter aortic valve replacement was associated with a numerically higher rate of death and disabling stroke at 30 days. This underscores the need for a better alternative surgical approach for patients with marginal femoral access...
January 2018: Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery
https://www.readbyqxmd.com/read/29440625/safety-and-feasibility-of-a-novel-active-fixation-temporary-pacing-lead
#14
Mark Webster, Sanjeevan Pasupati, Nigel Lever, Martin Stiles
OBJECTIVE: This first-in-human study evaluated the safety and technical feasibility of the Tempo temporary cardiac pacing lead (BioTrace Medical), which includes a novel fixation mechanism and soft tip. BACKGROUND: Complications of temporary pacing leads include dislodgment, arrhythmias, and ventricular perforation. Temporary pacing applications have increased with transcatheter aortic valve replacement (TAVR) growth, for rapid pacing during balloon valvuloplasty (BAV) and valve deployment, and for periprocedural bradyarrhythmia support...
February 15, 2018: Journal of Invasive Cardiology
https://www.readbyqxmd.com/read/29429630/transcatheter-aortic-valve-replacement-in-patients-with-severe-mitral-or-tricuspid-regurgitation-at-extreme-risk-for-surgery
#15
Stephen H Little, Jeffrey J Popma, Neal S Kleiman, G Michael Deeb, Thomas G Gleason, Steven J Yakubov, Stan Checuti, Daniel O'Hair, Tanvir Bajwa, Mubashir Mumtaz, Brijeshwar Maini, Alan Hartman, Stanley Katz, Newell Robinson, George Petrossian, John Heiser, William Merhi, B Jane Moore, Shuzhen Li, David H Adams, Michael J Reardon
OBJECTIVES: Patients with symptomatic severe aortic stenosis and severe mitral regurgitation or severe tricuspid regurgitation were excluded from the major transcatheter aortic valve replacement trials. We studied these 2 subgroups in patients at extreme risk for surgery in the prospective, nonrandomized, single-arm CoreValve US Expanded Use Study. METHODS: The primary end point was all-cause mortality or major stroke at 1 year. A favorable medical benefit was defined as a Kansas City Cardiomyopathy Questionnaire overall summary score greater than 45 at 6 months and greater than 60 at 1 year and with a less than 10-point decrease from baseline...
January 31, 2018: Journal of Thoracic and Cardiovascular Surgery
https://www.readbyqxmd.com/read/29420704/pacemaker-implantation-rate-after-transcatheter-aortic-valve-implantation-with-early-and-new-generation-devices-a-systematic-review
#16
Philippe J van Rosendael, Victoria Delgado, Jeroen J Bax
Aims: The incidence of new-onset conduction abnormalities requiring permanent pacemaker implantation (PPI) after transcatheter aortic valve implantation (TAVI) with new-generation prostheses remains debated. This systematic review analyses the incidence of PPI after TAVI with new-generation devices and evaluates the electrical, anatomical, and procedural factors associated with PPI. In addition, the incidence of PPI after TAVI with early generation prostheses was reviewed for comparison...
February 6, 2018: European Heart Journal
https://www.readbyqxmd.com/read/29413244/long-term-outcomes-in-patients-with-new-permanent-pacemaker-implantation-following-transcatheter-aortic-valve-replacement
#17
Chekrallah Chamandi, Marco Barbanti, Antonio Munoz-Garcia, Azeem Latib, Luis Nombela-Franco, Enrique Gutiérrez-Ibanez, Gabriela Veiga-Fernandez, Asim N Cheema, Ignacio Cruz-Gonzalez, Vicenç Serra, Corrado Tamburino, Antonio Mangieri, Antonio Colombo, Pilar Jiménez-Quevedo, Jaime Elizaga, Gerard Laughlin, Dae-Hyun Lee, Bruno Garcia Del Blanco, Tania Rodriguez-Gabella, Josep-Ramon Marsal, Mélanie Côté, François Philippon, Josep Rodés-Cabau
OBJECTIVES: This study sought to evaluate the long-term clinical impact of permanent pacemaker implantation (PPI) after transcatheter aortic valve replacement (TAVR). BACKGROUND: Conduction disturbances leading to PPI are common following TAVR. However, no data exist regarding the impact of PPI on long-term outcomes post-TAVR. METHODS: This was a multicenter study including a total of 1,629 patients without prior PPI undergoing TAVR (balloon- and self-expandable valves in 45% and 55% of patients, respectively)...
February 12, 2018: JACC. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29388705/echocardiography-in-transcatheter-aortic-valve-implantation-part-1-transthoracic-echocardiography
#18
REVIEW
Tasneem Z Naqvi
Transcatheter aortic valve replacement (TAVR) has been a revolutionary technique in the treatment of degenerative aortic valve stenosis. Selection of appropriate patients and appropriate valve size is crucial for improved patient outcome. Echocardiographic imaging is a critical component for patient selection and plays an important role in the selection of valve size, procedural guidance, and patient follow-up. This review discusses role of echocardiography in patient selection, device implantation, and postimplant follow-up for the first-generation CoreValve as used in pivotal trial...
February 1, 2018: Echocardiography
https://www.readbyqxmd.com/read/29386188/patient-specific-computer-simulation-to-elucidate-the-role-of-contact-pressure-in-the-development-of-new-conduction-abnormalities-after-catheter-based-implantation-of-a-self-expanding-aortic-valve
#19
Giorgia Rocatello, Nahid El Faquir, Gianluca De Santis, Francesco Iannaccone, Johan Bosmans, Ole De Backer, Lars Sondergaard, Patrick Segers, Matthieu De Beule, Peter de Jaegere, Peter Mortier
BACKGROUND: The extent to which pressure generated by the valve on the aortic root plays a role in the genesis of conduction abnormalities after transcatheter aortic valve replacement (TAVR) is unknown. This study elucidates the role of contact pressure and contact pressure area in the development of conduction abnormalities after TAVR using patient-specific computer simulations. METHODS AND RESULTS: Finite-element computer simulations were performed to simulate TAVR of 112 patients who had undergone TAVR with the self-expanding CoreValve/Evolut R valve...
February 2018: Circulation. Cardiovascular Interventions
https://www.readbyqxmd.com/read/29377318/trans-carotid-access-for-tavr-allows-safe-and-rapid-exchange-for-bailout-valve-in-valve-procedures
#20
Enrico Ferrari, Elena Caporali, Giovanni Pedrazzini, Stefanos Demertzis
Trans-carotid access for trans-catheter aortic valve replacement is a valid alternative in patients with aortic valve dysfunction, severe peripheral vascular disease, and high-risk for surgery. However, in the event of the need for a bailout valve-in-valve procedure, the safety of this access site is uncertain. We report a patient with aortic regurgitation, previous coronary surgery, peripheral vascular disease, and impaired ventricular function who underwent a CoreValve Evolut-R (Medtronic Inc, Minneapolis, MN) implantation through the left carotid artery followed by a successful valve-in-valve procedure with a 26-mm Edwards Sapien3 valve (Edwards Lifesciences, Irvine, CA) through the same carotid access site...
January 28, 2018: Journal of Cardiac Surgery
keyword
keyword
44526
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"